AACR ANNUAL MEETING 2026
On-demand posters
Thanks for your interest in our research. Here are our latest findings in the area of organoid screening, drug resistance, and ADC development presented during the Annual American Association for Caner Research 2026 event. Reach out to our team to connect with our scientists and discover how we can help you predict patient response and accelerate your oncology drug development pipeline.
TUMOR HETEROGENEITY
#701 Patient-derived Organoid Biobanks Preserve Tumor Heterogeneity and Molecular Signatures
TUMOR HETEROGENEITY
#699 Dynamic Adaptation and Heterogeneity in Tumor Patient-Derived Organoids: Insights into Cancer Evolution and Drug Resistance
ORGANOID SCREENING
#6404 A Robust Organoid-Based Platform for High-Throughput Screening and Drug Discovery
ADC INTERNALIZATION
#5702 An Image-based Approach to Visualize ADC Internalization and Cytotoxicity in Patient-derived Organoids
IMMUNE CEL CO-CULTURE
#5544 Organoid-PBMC Co-Cultures: A Robust Platform for Bispecific Antibody Immunotherapy Development
KRAS INHIBITOR TESTING
#3187 A Patient-derived Organoid Screening Platform as a Powerful Tool to Study Efficacy of KRAS Inhibitors
DRUG RESISTANCE
#3119 Modelling chemotherapy persistence in colorectal cancer using patient-derived organoids
PRECISION MEDICINE
#2515 Miniaturizing Patient-derived Organoid Screening Assays for Predictive Drug Testing
